Review Product Marketing Authorisation For Human Use «Epirubicin Ahcl»

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Epirubicina AHCL»

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-01-21&atto.codiceRedazionale=15A00310&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

Retrieved December 16, 2014 2014 # 2661/V&A of determines are authorized the following variation: introduction of the risk management plan, in relation to the drug EPIRUBICIN AHCL and authorised pack sizes the placing in Italy following the mutual recognition procedure.
How to: UK/H/1123/001/II/020.
Types of variation: C.I. 11. b).
A.I.C. Holder: Accord Healthcare Limit.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1, paragraph 5 of the April 14, 2014 # 371 determines AIFA published in Official Gazette No 101 of May 3, 2014.
Date of determination: this determination is effective on the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana and company will be notified to the holder of the marketing authorisation for the medicinal product.